Norbert Leclair

Senior Principal Scientist Genentech

Seminars

Thursday 10th December 2026
Advanced Assay Strategies for the Validation of Novel Complement Targets
2:00 pm
  • Detailing target-agnostic assay methodologies for characterizing complement inhibitors in early discovery
  • Elucidating strategies to enhance assay sensitivity and enable robust, cross-species evaluation of inhibitor potency and mechanism of action
  • Illustrating the broad, disease-agnostic application of these techniques

NEW SPEAKING COMPANY

Norbert Leclair Senior Principal Scientist Genentech - Expert Speaker at the 10th Complement-Based Drug Development Summit